A business in context

NUTX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-31 · 0001628280-26-059602 · Items 1.05

  2. 8-K · Current report

    Report date 2026-08-24 · 0001628280-26-058606 · Items 8.01

  3. 8-K · Current report

    Report date 2026-08-11 · 0001628280-26-056696 · Items 8.01

  4. 8-K · Current report

    Report date 2026-08-06 · 0001628280-26-054274 · Items 2.02,9.01

  5. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-054268

  6. 4 · Ownership change

    Report date 2026-07-31 · 0002018971-26-000003

  7. 4 · Ownership change

    Report date 2026-07-31 · 0001922252-26-000003

  8. 4 · Ownership change

    Report date 2026-07-31 · 0001920511-26-000003

  9. 4 · Ownership change

    Report date 2026-07-31 · 0001303609-26-000004

  10. 8-K · Current report

    Report date 2026-07-15 · 0001628280-26-049061 · Items 1.01

  11. 4 · Ownership change

    Report date 2026-06-04 · 0002018803-26-000003

  12. 4 · Ownership change

    Report date 2026-05-28 · 0001919945-26-000003

  13. 8-K · Current report

    Report date 2026-04-30 · 0001628280-26-028852 · Items 2.02,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-028849

  15. 4 · Ownership change

    Report date 2026-04-23 · 0002018971-26-000002

  16. 4 · Ownership change

    Report date 2026-04-23 · 0001922252-26-000002

  17. 8-K · Current report

    Report date 2026-04-23 · 0001628280-26-026828 · Items 5.07

  18. DEF 14A · Proxy statement

    Report date 2026-03-13 · 0001628280-26-017681

  19. 8-K · Current report

    Report date 2026-03-05 · 0001628280-26-015174 · Items 2.02,9.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-015168

  21. 8-K · Current report

    Report date 2025-11-24 · 0001628280-25-053849 · Items 8.01,9.01

  22. 8-K · Current report

    Report date 2025-11-19 · 0001628280-25-053170 · Items 2.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001628280-25-053166

  24. 8-K · Current report

    Report date 2025-11-18 · 0001628280-25-052962 · Items 2.02,9.01

  25. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001628280-25-052957

  26. 8-K · Current report

    Report date 2025-11-18 · 0001628280-25-052952 · Items 2.02,9.01

  27. 10-Q/A · Quarterly report

    Report date 2025-03-31 · 0001628280-25-052951

  28. 8-K · Current report

    Report date 2025-11-18 · 0001628280-25-052898 · Items 2.02,9.01

  29. 10-K/A · Annual report

    Report date 2024-12-31 · 0001628280-25-052895

  30. 8-K · Current report

    Report date 2025-10-20 · 0001479681-25-000085 · Items 2.02,3.01,9.01

  31. 8-K · Current report

    Report date 2025-09-16 · 0001479681-25-000083 · Items 5.02,7.01,9.01

  32. 8-K · Current report

    Report date 2025-09-08 · 0001479681-25-000077 · Items 8.01

  33. 8-K · Current report

    Report date 2025-09-04 · 0001479681-25-000072 · Items 5.02

  34. 8-K · Current report

    Report date 2025-08-22 · 0001479681-25-000070 · Items 8.01

  35. 8-K · Current report

    Report date 2025-08-20 · 0001479681-25-000068 · Items 2.02,3.01,4.02,8.01,9.01

  36. 8-K · Current report

    Report date 2025-08-14 · 0001479681-25-000058 · Items 2.02

  37. 8-K · Current report

    Report date 2025-07-14 · 0001628280-25-035002 · Items 5.07,9.01

  38. 8-K · Current report

    Report date 2025-07-08 · 0001628280-25-034795 · Items 5.02,9.01

  39. DEF 14A · Proxy statement

    Report date 2025-06-02 · 0001479681-25-000035

  40. 8-K · Current report

    Report date 2025-05-21 · 0001479681-25-000028 · Items 4.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 4 transaction rows4AExercise / conversion: 1 transaction rows1MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

8 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-04
2026-06-04
Spears KelvinJ · Other (see filing)
Acquired
Common Stock2519.00.0
2026-05-28
2026-05-29
Vo Thomas T.J · Other (see filing)
Acquired
Common Stock75747.00.0
2026-04-23
2026-04-24
Saunders Scott JA · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
823.00.0
2026-04-23
2026-04-24
Reed Michael LeeA · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
823.00.0
2026-04-23
2026-04-24
Grenas Cheryl YvonneA · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
823.00.0
2026-04-23
2026-04-24
Jaumot Frank EA · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
823.00.0
2026-04-09
2026-04-10
Vo Thomas T.J · Other (see filing)
Acquired
Common Stock184071.00.0
2026-03-10
2026-04-10
Vo Thomas T.M · Exercise / conversion
Acquired
Restricted Stock Units
Derivative security
4841.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001479681Nutex Health Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • Nutex Health, Inc. · former SEC name · 2022-04-04 to 2026-02-11
  • Clinigence Holdings, Inc. · former SEC name · 2019-11-14 to 2022-03-31
  • iGambit, Inc. · former SEC name · 2009-12-31 to 2019-11-13

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$479.95M$510.89M
2023-12-31$247.65M$271.37M
2022-12-31$219.29M$250.17M
2021-12-31$331.53M$408.48M
2020-12-31$274.03M$353.55M
2019-12-31$1.37M$1.78M
2018-12-31$1.37M$1.82M
2017-12-31$23.2K$31.6K

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗